CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Cardene In 0.83% Sodium Chloride In Plastic Container patents expire, and when can generic versions of Cardene In 0.83% Sodium Chloride In Plastic Container launch?
Cardene In 0.83% Sodium Chloride In Plastic Container is a drug marketed by Chiesi and is included in one NDA. There are six patents protecting this drug.
This drug has twenty-one patent family members in ten countries.
The generic ingredient in CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cardene In 0.83% Sodium Chloride In Plastic Container
A generic version of CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER was approved as nicardipine hydrochloride by ANI PHARMS on October 28th, 1996.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER?
- What are the global sales for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER?
Summary for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
International Patents: | 21 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 55 |
Clinical Trials: | 9 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER |
DailyMed Link: | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Boston Medical Center | Phase 4 |
Vanderbilt University Medical Center | Phase 2 |
National Institute of Neurological Disorders and Stroke (NINDS) | Phase 2 |
See all CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER clinical trials
Pharmacology for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
US Patents and Regulatory Information for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER is protected by six US patents.
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | AP | RX | Yes | Yes | 7,659,291 | ⤷ Subscribe | ⤷ Subscribe | |||
Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | AP | RX | Yes | Yes | 10,758,616 | ⤷ Subscribe | Y | ⤷ Subscribe | ||
Chiesi | CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER | nicardipine hydrochloride | INJECTABLE;INTRAVENOUS | 019734-004 | Nov 7, 2008 | AP | RX | Yes | Yes | 11,547,758 | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
See the table below for patents covering CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
South Korea | 20090040258 | ⤷ Subscribe | |
Switzerland | 605755 | ⤷ Subscribe | |
Japan | S49109384 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental
More… ↓